News
QUANTRO Therapeutics appoints Dr. Elmar Maier as Independent Board Chairman
QUANTRO Therapeutics GmbH today announced the appointment of Dr. Elmar Maier as Independent Chairman of its Board.
Nabriva Therapeutics to Report First Quarter 2021 Financial Results and Recent Corporate Highlights on May 6, 2021
Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of…
MedUni Vienna: Focus on advancing immunomodulating cancer treatments
Christian Doppler Laboratory for Personalized Immunotherapy opened at MedUni Vienna
124 Mio. Euro an zusätzlichen EU-Regionalfördermitteln für Österreich
Im Wiederaufbauprogramm der EU wird auch die Kohäsionspolitik gestärkt
MSD stellt seinen Mitarbeiter:innen Hautkrebs-Früherkennungs-App SkinScreener zur Verfügung
MSD Österreich stellt allen Mitarbeiter:innen eine Jahreslizenz der Hautkrebs-Früherkennungs-App SkinScreener zur…
Valneva Announces Launch of Proposed Global Offering, Start of the Roadshow and Nasdaq Listing
Valneva SE (the “Company”), a specialty vaccine company focused on the development and commercialization of prophylactic…
TAmiRNA brings new miRNA insights to ECTS 2021 – Digital congress
Biotech innovators TAmiRNA is returning to the European Calcified Tissue Society (ECTS) Congress, this time being staged…
Trusted Knowledge und künstliche Intelligenz: HealthTech Start-up XUND unterstützt mit Thieme Inhalten die Gesundheitskompetenz des Einzelnen
Die Qualität von und den Zugang zu medizinischen Informationen zu erleichtern, das sind die selbstgesteckten Ziele der…
"Pollen and Allergies": new edition of the self-help book from MedUni Vienna and MANZ Verlag focussing on climate change and Covid-19
An updated, second edition of the MedUni Vienna self-help book "Pollen and Allergies – Identifying and Alleviating…
Wissenschaftsfonds FWF förderte im Jahr 2020 exzellente Grundlagenforschung im Umfang von 243,6 Millionen Euro
Aktuell bringen in Österreich 4.343 Forschende dank einer FWF-Förderung den Erkenntnisgewinn in allen Bereichen der…
Sanofi mit dem equalitA Gütesiegel für Gender Balance Maßnahmen ausgezeichnet
Das staatliche Gütesiegel bestätigt Sanofis Engagement für besondere innerbetriebliche Frauenförderung und…
AFFiRiS: Positive preclinical in vivo results with AFFiRiS' antibody MAB C6-17 to treat Huntington's Disease to be presented at the 16th Annual Huntington's Disease Therapeutics Conference
· Monoclonal antibody C6-17 designed to target mutant huntingtin protein (mtHTT) and to reduce spread of Huntington’s…
The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.
As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.